PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $46,000 | -73.7% | 12,225 | -64.5% | 0.00% | – |
| Q4 2019 | $175,000 | +250.0% | 34,434 | +198.1% | 0.00% | – |
| Q1 2016 | $50,000 | -42.5% | 11,552 | -19.0% | 0.00% | – |
| Q4 2015 | $87,000 | -6.5% | 14,259 | -12.5% | 0.00% | – |
| Q3 2015 | $93,000 | -35.9% | 16,300 | -16.4% | 0.00% | – |
| Q2 2015 | $145,000 | -67.6% | 19,496 | -73.9% | 0.00% | -100.0% |
| Q1 2015 | $447,000 | -72.7% | 74,734 | -65.5% | 0.00% | -50.0% |
| Q4 2014 | $1,638,000 | +411.9% | 216,635 | +251.6% | 0.00% | – |
| Q3 2014 | $320,000 | +566.7% | 61,613 | +427.1% | 0.00% | – |
| Q1 2014 | $48,000 | -97.8% | 11,689 | -97.1% | 0.00% | -100.0% |
| Q4 2013 | $2,168,000 | -25.0% | 406,763 | -29.3% | 0.00% | -40.0% |
| Q3 2013 | $2,892,000 | +28.6% | 575,094 | +14.1% | 0.01% | +25.0% |
| Q2 2013 | $2,248,000 | – | 504,093 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|